Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: Cancer Chemother Pharmacol. 2018 Dec 8;83(3):473–482. doi: 10.1007/s00280-018-3749-7

Figure 3.

Figure 3.

Correlation of dasatinib levels in normal endometrium with levels in adjacent tumor of each patient in the study. Blue (Dose level 1); Red (Dose level 2).